Publications

5674 Results

Dietary behavior change for bowel symptom management in rectal cancer survivors: the Altering Intake, Managing Symptoms (AIMS) intervention

Authors
V Sun;TE Crane;SD Slack;A Yung;S Wright;R Krouse;CA Thomson
Journal / Conference
ASPO 42nd Annual Conference (Mar 10-13, 2018, New York, NY), poster
Year
2018
Research Committee(s)
Cancer Survivorship

Effect of age, gender, and performance status (PS) on the duration results of adjuvant chemotherapy for stage III colon cancer: The IDEA collaboration

Authors
A Shields;FS Ou;J Paul;A Sobrero;T Yoshino;J Taieb;I Souglakos;Q Shi;R Kerr;R Labianca;T Yamanaka;D Vernerey;I Boukovinas;T Kato;V Torri;S Kakolyris;T Andre;T Grothey;J Meyerhardt;T Iveson
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 3599); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80702

Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer

Authors
JK Parsons;JP Pierce;J Mohler;E Paskett;S-H Jung;MJ Morris;E Small;O Hahn;P Humphrey;JR Marshall
Journal / Conference
British Journal of Urology International Apr;121(4):534-539
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID28437029
PMC
PMC5654696
Study Number(s)
CTSU/C70807

Phase 1/2 Trial of GCLAM with Dose-Escalated Mitoxantrone for Newly Diagnosed AML or Other High-Grade Myeloid Neoplasms

Authors
A Halpern;M Othus;E Huebner;BL Scott;P Becker;M Percival;P Hendrie;KM Gardner;TL Chen;S Buckley;KF Orlowski;A Anwar;F Appelbaum;H Erba;E Estey;R Walter
Journal / Conference
Leukemia Nov;32(11):2352-2362; Apr 17 [Epub ahead of print]
Year
2018
Research Committee(s)
Leukemia
PMID
PMID29720734
PMC
PMC6192860
Study Number(s)
S0106

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Authors
J Sparano;RJ Gray;D Makower;K Pritchard;K Albain;D Hayes;CE Geyer;E Dees;M Goetz;J Olson, JR;J Abrams;T Lively;S Badve;TJ Saphner;L Wagner;T Whelan;M Ellis;L Paik;WC Wood;P Ravdin;M Keane;H Gomez Moreno;PS Reddy;T Goggins;I Mayer;A Brufsky;D Toppmeyer;V Kaklamani;J Berenberg;G Sledge
Journal / Conference
New England Journal of Medicine Jul 12;379(2):111-121
Year
2018
Research Committee(s)
Breast
PMID
PMID29860917
PMC
PMC6172658

Estimating global treatment toxicity burden from adverse-event data

Authors
SM Lee;DL Hershman;J Miao;X Zhong;J Unger;Y Cheung
Journal / Conference
Cancer Feb 15;124(4):858-864. Epub 2017 Nov 7
Year
2018
Research Committee(s)
Genitourinary
PMID
PMID29112232
PMC
PMC5801103
Study Number(s)
S9916

Association of sex and adverse events (AEs) of adjuvant chemotherapy (ACT) in early stage colon cancer (CC): A pooled analysis of 28,636 patients (pts) in the ACCENT database

Authors
AD Wagner;A Grothey;T Andre;J Dixon;N Wolmark;D Haller;CJ Allegra;E VanCutsem;T George;A DeGramont;S Alberts;C Twelves;M O'Connell;L Saltz;C Blanke;G Francini;R Kerr;R Goldberg;G Yothers;Q Shi
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 3603); ASCO 2018 Annual Meeting (June 1-5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

CA15-3/MUC1 in CCTG MA.32: A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer

Authors
R Dowling;W Parulekar;K Gelmon;L Shepherd;S Virk;M Ennis;F Mao;J Ligibel;D Hershman;R Rastogi;I Mayer;T Hobday;J Lemieux;AM Thompson;M Rabaglio-Poretti;T Whelan;V Stamboic;B Chen;P Goodwin
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 557); ASCO Annual Meeting (June 1-5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Breast

Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study (NRG- GI004/SWOG-S1610): A randomized phase III study of mFOLFOX6/ bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer

Authors
J Lee;G Yothers;SA Jacobs;H Sanoff;D Cohen;K Guthrie;NL Henry;P Ganz;PC Lucas;C Allegra;C Blanke;N Wolmark;H Hochster;TJ George;M Overman
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr TPS3615); ASCO Annual Meeting (June 1-5, 2018, Chicago, IL), poster session
Year
2018
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/NRG-GI004

Phase III, randomized, double blind, placebo-controlled trial of sorafenib in desmoid tumors (Alliance A091105)

Authors
M Gounder;MR Mahoney;BA Van Tine;V Ravi;S Attia;H Deshpande;A Gupta;M Milhem;R Conry;S Movva;M Pishvaian;J Crawford;T Sabagh;R Maki;W Tapp;R Lefkowitz;N Agaram;JJ Wright;A Dueck;GK Schwartz
Journal / Conference
J Clin Oncol 36, 2018 (suppl; abstr 11500); ASCO Annual Meeting (June 1-5, 2018, Chicago, IL), oral
Year
2018